Exact Mass: 279.0729
Exact Mass Matches: 279.0729
Found 58 metabolites which its exact mass value is equals to given mass value 279.0729,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N-[4'-hydroxy-(E)-cinnamoyl]-L-aspartic acid
N-[4-hydroxy-(E)-cinnamoyl]-L-aspartic acid is a cocoa metabolite from gut microflora. It is found n urine. Constituent of Arabidopsis thalianaand is also found in roasted cocoa beans and coffee powder [CCD].
(2R,4S)-2-Aminoformyl-6-fluoro-spiro[chroman-4,4'-imidazolidine]-2',5'-dione
Fexinidazole
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01C - Agents against leishmaniasis and trypanosomiasis > P01CA - Nitroimidazole derivatives C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Imepitoin
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent Imepitoin (AWD 131-138) is a new low-affinity partial benzodiazepine receptor agonist with potent anticonvulsant and anxiolytic properties in rodent models.
ZLJ-6
N-[4-hydroxy-(E)-cinnamoyl]-L-aspartic acid
1-CYCLOPROPYL-6,7-DIFLUORO-5-METHYL-4-OXO-3-QUINOLINE CARBOXYLIC ACID
1-(4-CHLOROPHENYL)-3-MORPHOLINO-1H-PYRAZOL-5(4H)-ONE
1-[3-chloro-5-(trifluoromethyl)-2-pyridyl]-1,4-diazepane
4-[2-(chloromethyl)-4-(trifluoromethyl)phenyl]morpholine
(s)-(+)-3-(benzyloxycarbonyl)-5-oxo-4-oxazolidineacetic acid
Acetamide,2-chloro-N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-
4-[4-Chloro-3-(trifluoromethyl)phenyl]-4-piperidinol
(2-(BUTYLTHIO)-5-(TRIFLUOROMETHYL)PYRIDIN-3-YL)BORONIC ACID
3-benzylhydroxy-6-hydroxymethylpyridine-2-carboxaldehyde hydrochloride
(2-(ISOBUTYLTHIO)-5-(TRIFLUOROMETHYL)PYRIDIN-3-YL)BORONIC ACID
Acrylic acid-2-acrylamido-2-methyl propane sulfonic acid copolymer
It is used as a food additive .
4-Chloro-6-ethoxyquinoline-3-carboxylic acid ethyl ester
Benzenemethanol, 2-chloro-a-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-, hydrochloride (1:1)
[5-furan-2-yl-4-(2-methyl-allyl)-4 h-[1,2,4]triazol-3-ylsulfanyl]-acetic acid
7-PHENYL-1-(PROP-2-YNYL)-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE
(+/-)-8,9-Difluoro-5-methyl-6,7-dihydro-1-oxo-1H,5H-bnezo[i,j]quinolizine-2-carboxylic acid
2-[3-cyano-4-(4-fluorophenyl)-5,5-dimethylfuran-2-ylidene]propanedinitrile
Phosphonic acid,P-(aminophenylmethyl)-, diethyl ester, hydrochloride (1:1)
2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzonitrile
ETHYL 8-CHLORO-1-ETHYL-4-OXO-4H-QUINOLIZINE-3-CARBOXYLATE
methyl 1-cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate
Ethyl 2-amino-4-(4-fluorophenyl)-5-methyl-thiophene-3-carboxylate
3-(3-Fluoro-4-hydroxyphenyl)-7-hydroxy-1-naphthonitrile
3-chloro-2,2-dimethyl-N-[4-(trifluoromethyl)phenyl]propanamide
Taribavirin hydrochloride
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent
6-Fluoro-2,5-dioxo-2,3-dihydrospiro[chromene-4,4-imidazolidine]-2-carboxamide
(2S,4R)-2-Aminoformyl-6-fluoro-spiro[chroman-4,4-imidazolidine]-2,5-dione
Fexinidazole
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01C - Agents against leishmaniasis and trypanosomiasis > P01CA - Nitroimidazole derivatives C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
2-methoxy-N-methyl-N-[5-(5-methyl-2-pyrazinyl)-1,3,4-thiadiazol-2-yl]acetamide
1-S-(N-hydroxybut-3-enimidoyl)-1-thio-beta-D-glucopyranose
[5-(4-chlorophenyl)-1-isopropyl-1H-1,2,4-triazol-3-yl]acetic acid
2-Chloro-3-(3-methoxypropylimino)naphthalene-1,4-dione
6-Chloro-3-(3,3-dimethyl-2-oxobutyl)-1,4-benzoxazin-2-one
6-Chloro-3-(4-methyl-2-oxopentyl)-1,4-benzoxazin-2-one
desulfosinigrin
A desulfoglucosinolic acid resulting from the formal condensation of the thiol group of N-hydroxybut-3-enethioamide with beta-D-glucopyranose.
UCM-1306
UCM-1306 is a potent and orally active human dopamine D1 receptor allosteric modulator (PAM). UCM-1306 increases the endogenous dopamine (DA) maximal effect both in human and mouse D1 receptors. UCM-1306 is not only for improving motor symptoms but also for addressing the key comorbid cognitive impairment associated with long-term Parkinson’s disease (PD)[1].
